Drug Patents owned by Primus Pharms

1. Drug name - IMPOYZ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10588914 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US10064875 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9956231 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9855334 PRIMUS PHARMS Topical compositions comprising a corticosteroid Mar, 2035

(12 years from now)

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Treatment: Treatment of moderate to severe plaque psoriasis in patients 18 years of age or older; Treatment of moderate plaque psoriasis; treatment of plaque psoriasis; psoriasis; treatment of plaque psoriasis in patients 18 years of age or older; twice daily topical treatment of moderate to severe plaque psoriasis.; Treatment of moderate plaque psoriasis; treatment of plaque psoriasis in patients 18 years of age or older; psoriasis; twice daily topical treatment of moderate to severe plaque psoriasis.; treatment of plaque psoriasis; plaque psoriasis

Dosage: CREAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.025% CREAM;TOPICAL Prescription

2. Drug name - SERNIVO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9364485 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9655907 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US10179137 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9433630 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9877974 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9439911 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

US9775851 PRIMUS PHARMS Topical formulations comprising a steroid Aug, 2030

(7 years from now)

Drugs and Companies using BETAMETHASONE DIPROPIONATE ingredient

Treatment: Treatment of plaque psoriasis

Dosage: SPRAY;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 0.05% BASE/SPRAY SPRAY;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.